References

Aso K, Shahtaheri SM, Hill R Associations of symptomatic knee osteoarthritis with histopathologic features in subchondral bone. Arthritis Rheumatol. 2019; 71:(6)916-924 https://doi.org/10.1002/art.40820

Aso K, Shahtaheri SM, Hill R Contribution of nerves within osteochondral channels to osteoarthritis knee pain in humans and rats. Osteoarthritis Cartilage. 2020; 28:(9)1245-1254 https://doi.org/10.1016/j.joca.2020.05.010

Belshaw Z, Dean R, Asher L. You can be blind because of loving them so much: the impact on owners in the united kingdom of living with a dog with osteoarthritis. BMC Vet Res. 2020; 16:(1) https://doi.org/10.1186/s12917-020-02404-5

Brown DC, Boston RC, Coyne JC, Farrar JT. Ability of the canine brief pain inventory to detect response to treatment in dogs with osteoarthritis. J Am Vet Med Assoc. 2008; 233:(8)1278-1283 https://doi.org/10.2460/javma.233.8.1278

Brown DC, Bell M, Rhodes L. Power of treatment success definitions when the canine brief pain inventory is used to evaluate carprofen treatment for the control of pain and inflammation in dogs with osteoarthritis. Am J Vet Res. 2013a; 74:(12)1467-1473 https://doi.org/10.2460/ajvr.74.12.1467

Brown DC, Boston RC, Farrar JT. Comparison of force plate gait analysis and owner assessment of pain using the canine brief pain inventory in dogs with osteoarthritis. J Vet Intern Med. 2013b; 27:(1)22-30 https://doi.org/10.1111/jvim.12004

Cachon T, Frykman O, Innes JF Face validity of a proposed tool for staging canine osteoarthritis: canine osteoarthritis staging tool (coast). Vet J. 2018; 235:1-8 https://doi.org/10.1016/j.tvjl.2018.02.017

de Lange-Brokaar BJE, Kloppenburg M, Andersen SN Characterization of synovial mast cells in knee osteoarthritis: association with clinical parameters. Osteoarthritis Cartilage. 2016; 24:(4)664-671 https://doi.org/10.1016/j.joca.2015.11.011

Eitner A, Hofmann GO, Schaible HG. Mechanisms of osteoarthritic pain. Studies in humans and experimental models. Front Mol Neurosci. 2017; 10 https://doi.org/10.3389/fnmol.2017.00349

Enomoto M, Mantyh PW, Murrell J, Innes JF, Lascelles BDX. Anti-nerve growth factor monoclonal antibodies for the control of pain in dogs and cats. Vet Rec. 2019; 184:(1) https://doi.org/10.1136/vr.104590

European Medicines Agency. Solensia. 2021a. https://www.ema.europa.eu/en/medicines/veterinary/EPAR/solensia

European Medicines Agency. Librela. 2021b. https://www.ema.europa.eu/en/medicines/veterinary/EPAR/librela

Forster KE, Wills A, Torrington AM Complications and owner assessment of canine total hip replacement: a multicenter internet based survey. Vet Surg. 2012; 41:(5)545-550 https://doi.org/10.1111/j.1532-950X.2012.01015.x

Godfrey D, Vaughan L. Historical prevalence of radiological appendicular osteoarthritis in cats (1972-1973). J Am Anim Hosp Assoc. 2018; 54:(4)209-212 https://doi.org/10.5326/JAAHA-MS-6555

Gruen ME, Thomson AE, Griffith EH A feline-specific anti-nerve growth factor antibody improves mobility in cats with degenerative joint disease-associated pain: a pilot proof of concept study. J Vet Intern Med. 2016; 30:(4)1138-1148 https://doi.org/10.1111/jvim.13972

Gruen ME, Myers JAE, Lascelles BDX. Efficacy and safety of an anti-nerve growth factor antibody (frunevetmab) for the treatment of degenerative joint disease-associated chronic pain in cats: a multisite pilot field study. Front Vet Sci. 2021; 8 https://doi.org/10.3389/fvets.2021.610028

Hardie EM, Roe SC, Martin FR. Radiographic evidence of degenerative joint disease in geriatric cats: 100 cases (1994–1997). J Am Vet Med Assoc. 2002; 220:(5)628-632 https://doi.org/10.2460/javma.2002.220.628

Hercock CA, Pinchbeck G, Giejda A, Clegg PD, Innes JF. Validation of a client-based clinical metrology instrument for the evaluation of canine elbow osteoarthritis. J Small Animal Pract. 2009; 50:(6)266-271 https://doi.org/10.1111/j.1748-5827.2009.00765.x

Hielm-Bjorkman AK, Rita H, Tulamo RM. Psychometric testing of the Helsinki chronic pain index by completion of a questionnaire in Finnish by owners of dogs with chronic signs of pain caused by osteoarthritis. Am J Vet Res. 2009; 70:(6)727-734 https://doi.org/10.2460/ajvr.70.6.727

Innes J, O'Neill T, Lascelles D. Use of non-steroidal anti-inflammatory drugs for the treatment of canine osteoarthritis. In Pract. 2010; 32:(4)126-137 https://doi.org/10.1136/inp.c1436

Innes J. Arthritis, 2nd edn. In: Johnston S, Tobias K (eds). Missouri USA: Elsevier; 2018

Lane NE, Schnitzer TJ, Birbara CA Tanezumab for the treatment of pain from osteoarthritis of the knee. N Engl J Med. 2010; 363:(16)1521-1531 https://doi.org/10.1056/NEJMoa0901510

Lascelles BDX, Hansen BD, Roe S Evaluation of client-specific outcome measures and activity monitoring to measure pain relief in cats with osteoarthritis. J Vet Intern Med. 2007; 21:(3)410-416 https://doi.org/10.1111/j.1939-1676.2007.tb02983.x

Lascelles BDX, Knazovicky D, Case B A canine-specific anti-nerve growth factor antibody alleviates pain and improves mobility and function in dogs with degenerative joint disease-associated pain. BMC Vet Res. 2015; 11:(1) https://doi.org/10.1186/s12917-015-0413-x

McNamee KE, Burleigh A, Gompels LL Treatment of murine osteoarthritis with trkad5 reveals a pivotal role for nerve growth factor in non-inflammatory joint pain. Pain. 2010; 149:(2)386-392 https://doi.org/10.1016/j.pain.2010.03.002

Miller RJ, Malfait AM, Miller RE. The innate immune response as a mediator of osteoarthritis pain. Osteoarthritis Cartilage. 2020; 28:(5)562-571 https://doi.org/10.1016/j.joca.2019.11.006

Monteiro BP. Feline chronic pain and osteoarthritis. Vet Clin North Am-Small Anim Pract. 2020; 50:(4)769-788 https://doi.org/10.1016/j.cvsm.2020.02.003

O'Neill DG, Church DB, McGreevy PD, Thomson PC, Brodbelt DC. Prevalence of disorders recorded in dogs attending primary-care veterinary practices in England. PloS One. 2014; 9:(3) https://doi.org/10.1371/journal.pone.0090501

Orlowsky EW, Kraus VB. The role of innate immunity in osteoarthritis: when our first line of defense goes on the offensive. J Rheumatol. 2015; 42:(3)363-371 https://doi.org/10.3899/jrheum.140382

Pettitt RA, German AJ. Investigation and management of canine osteoarthritis. In Pract. 2015; 37:(S1)1-8 https://doi.org/10.1136/inp.h5763

Rausch-Derra L, Huebner M, Wofford J, Rhodes L. A prospective, randomized, masked, placebo-controlled multisite clinical study of grapiprant, an ep4 prostaglandin receptor antagonist (pra), in dogs with osteoarthritis. J Vet Intern Med. 2016; 30:(3)756-763 https://doi.org/10.1111/jvim.13948

Schmelz M, Mantyh P, Malfait AM Nerve growth factor antibody for the treatment of osteoarthritis pain and chronic low-back pain: mechanism of action in the context of efficacy and safety. Pain. 2019; 160:(10)2210-2220 https://doi.org/10.1097/j.pain.0000000000001625

Vincent TL. Peripheral pain mechanisms in osteoarthritis. Pain. 2020; 161:S138-S146 https://doi.org/10.1097/j.pain.0000000000001923

von Loga IS, El-Turabi A, Jostins L Active immunisation targeting nerve growth factor attenuates chronic pain behaviour in murine osteoarthritis. Ann Rheum Dis. 2019; 78:(5)672-675 https://doi.org/10.1136/annrheumdis-2018-214489

Walsh DA, McWilliams DF, Turley MJ Angiogenesis and nerve growth factor at the osteochondral junction in rheumatoid arthritis and osteoarthritis. Rheumatology. 2010; 49:(10)1852-1861 https://doi.org/10.1093/rheumatology/keq188

Walton MB, Cowderoy E, Lascelles D, Innes JF. Evaluation of construct and criterion validity for the ‘Liverpool osteoarthritis in dogs’ (load) clinical metrology instrument and comparison to two other instruments. PloS One. 2013; 8:(3) https://doi.org/10.1371/journal.pone.0058125

Walton B, Cox T, Innes J. How do I know my animal got better?’ – measuring outcomes in small animal orthopaedics. In Pract. 2018; 40:(2)42-50 https://doi.org/10.1136/inp.k647

Westgarth C, Christley RM, Jewell C Dog owners are more likely to meet physical activity guidelines than people without a dog: an investigation of the association between dog ownership and physical activity levels in a UK community. Sci Rep. 2019; 9:(1) https://doi.org/10.1038/s41598-019-41254-6

Zhu SA, Zhu JX, Zhen GH Subchondral bone osteoclasts induce sensory innervation and osteoarthritis pain. J Clin Invest. 2019; 129:(3)1076-1093 https://doi.org/10.1172/JCI121561

Understanding and managing pain in the arthritic synovial joint: an update

02 January 2022
10 mins read
Volume 27 · Issue 1

Abstract

Osteoarthritis is a very common cause of chronic pain in dogs and cats. Great progress has been made in the last 2–3 decades in unravelling the molecular mediators of joint pain. Now we are starting to see the benefits of this research in terms of new targets to block joint pain and new medicines reaching our pharmacy shelves. This review summarises the progress that has been made in understanding why and how arthritic joints cause pain. This will help readers understand novel medicines and provide insight into the others that might follow in the future.

Osteoarthritis is an incurable condition that is slowly progressive and a cause of chronic pain. Chronic joint pain is a real challenge for veterinary teams to manage, a source of considerable anxiety for pet owners and a welfare issue for dogs and cats. Estimates suggest that 7–20% of adult dogs have osteoarthritis, although case definitions vary in the literature (O'Neill et al, 2014; Pettitt and German, 2015). For cats, it is estimated that over 70% of older cats have radiographic osteoarthritis (Hardie et al, 2002; Godfrey and Vaughan, 2018; Monteiro, 2020). Some studies have highlighted the negative impact that osteoarthritis has not only on an affected pet, but also on the wellbeing of pet owners (Belshaw et al, 2020). The author has frequently witnessed the extreme disappointment that owners feel when they realise that their dog has a problem that might limit their mobility and ability to exercise. After all, taking the dog for a walk is beneficial for the physical and mental health of both dogs and owners alike (Westgarth et al, 2019).

Register now to continue reading

Thank you for visiting UK-VET Companion Animal and reading some of our peer-reviewed content for veterinary professionals. To continue reading this article, please register today.